Stockholm, Sweden: Nano-sized molecules from certain chemical elements can inhibit plaque formation in brain tissue.The discovery by researchers at the…
US regulators on Monday approved Biogen Inc's aducanumab as the first treatment to address an underlying cause of Alzheimer's disease…